Fresh Cells Alert
Beta-Pro Investors
Beta-Pro Virtual Tour
Contact Beta-Pro
Paul Manning  |   Cindy Barber  |   Ken Brayman

Kenneth L. Brayman, M.D., Ph.D.

Beta-Pro Scientific Advisor

Kenneth L. Brayman, M.D., Ph.D., is the scientific advisor of Beta-Pro. He is also a professor of surgery at the University of Virginia (UVa), where he directs the renal, pancreas and human islet cell transplant programs at the UVa Medical Center. During his tenure, he has doubled the size of the transplant program and has established UVa as the premier regional center for diabetes treatment through islet cell transplantation.

Before joining UVa in September 2002, Dr. Brayman directed the pancreas transplant program at the Hospital of the University of Pennsylvania and the renal transplant program at the Children's Hospital of Philadelphia. He also lead the Human Islet Transplant Program at the University of Pennsylvania from 1992-1999.

Under Dr. Brayman's direction, the University of Pennsylvania performed six successful islet cell transplants in non-uremic patients with type 1 diabetes. The patients, who required insulin and suffered from hypoglycemic unawareness (an inability to sense low blood sugar) before receiving islet cell transplants, enjoyed freedom from insulin administration after transplantation.

Dr. Brayman’s research interests are in islet cell transplantation, transplantation tolerance, gene therapy, and xenotransplantation. He is a graduate of the University of Pennsylvania School of Medicine, where he earned his M.D. and Ph.D., and the University of Massachusetts, Amherst, where he earned a B.S. in biochemistry.
HomeContact UsSite Map © 2008 Beta-Pro LLC    
Beta-Pro (www.betaprollc.com) is dedicated to compliance with all existing federal, state, and institutional requirements pertaining to the collection and use of cells. Strict procedures are in place to protect the privacy and confidentiality of all volunteer donors, including coding procedures for cells and associated clinical information, so that a donor’s identity is inaccessible to Beta-Pro and researchers.